RecruitingPHASE1, PHASE2NCT07513038
Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia
Studying Digestive tract malformation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston Children's Hospital
- Intervention
- Indocyanine Green (ICG)(drug)
- Enrollment
- 20 target
- Eligibility
- All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- Boston Children's Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07513038 on ClinicalTrials.govOther trials for Digestive tract malformation
Additional recruiting or active studies for the same condition.